HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.

Because NIKA's goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.

After the necessary funds have been secured, the pharmaceutical factory will be constructed within four months, with ITV-1 launched within 45 days thereafter. This will secure NIKA's future investment development by providing access to its own capital through ...